POTENTIAL DEAL DETAILS
|Stock||Magellan Health, Inc.||Symbol||MGLN|
|Date of Confirmation:||01/04/2021||Price at Confirmation:||$82.84|
|Potential Profit:||17.75%||Annualized Profit:||9.47%|
U.S. healthcare plan and pharmacy benefits manager Magellan Health Inc (MGLN) will explore selling itself after coming under pressure to do so from activist hedge fund Starboard Value LP, people familiar with the matter said on Wednesday.
June 26, 2019: Managed-care provider Magellan Health Inc. (MGLN) is in exclusive talks for a possible sale to private-equity firm Centerbridge Partners LP, according to people familiar with the matter.
Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.